Article
p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Feb 2000
Murakami I, Hiyama K, Ishioka S, Yamakido M, Kasagi F, Yokosaki Y
Abstract excerpt
Mutations in the p53 gene are common in many cancers. Nevertheless, the relationship between mutations of this tumor suppressor gene and patient survival in non-small cell lung cancer (NSCLC) remains unclear. Interpretation of prior studies of patient outcomes are complicated by the inclusion of both surgical and nonsurgical patients. To better isolate the potential effects of p53 gene mutations per se on tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
